These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 26844828)

  • 1. Prions and Protein Assemblies that Convey Biological Information in Health and Disease.
    Sanders DW; Kaufman SK; Holmes BB; Diamond MI
    Neuron; 2016 Feb; 89(3):433-48. PubMed ID: 26844828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstructing prions: fibril assembly from simple yeast to complex mammals.
    Sigurdson C; Polymenidou M; Aguzzi A
    Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.
    Jucker M; Walker LC
    Nat Neurosci; 2018 Oct; 21(10):1341-1349. PubMed ID: 30258241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prions and Prion-like assemblies in neurodegeneration and immunity: The emergence of universal mechanisms across health and disease.
    O'Carroll A; Coyle J; Gambin Y
    Semin Cell Dev Biol; 2020 Mar; 99():115-130. PubMed ID: 31818518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
    Tarutani A; Hisanaga SI; Hasegawa M
    Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.
    Pearce MM
    Curr Opin Genet Dev; 2017 Jun; 44():149-155. PubMed ID: 28441621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-like transmission of protein aggregates in neurodegenerative diseases.
    Brundin P; Melki R; Kopito R
    Nat Rev Mol Cell Biol; 2010 Apr; 11(4):301-7. PubMed ID: 20308987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular prion protein mediates toxic signaling of amyloid beta.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast prions: structure, biology, and prion-handling systems.
    Wickner RB; Shewmaker FP; Bateman DA; Edskes HK; Gorkovskiy A; Dayani Y; Bezsonov EE
    Microbiol Mol Biol Rev; 2015 Mar; 79(1):1-17. PubMed ID: 25631286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide sequences converting polyglutamine into a prion in yeast.
    Odani W; Urata K; Okuda M; Okuma S; Koyama H; Pack CG; Fujiwara K; Nojima T; Kinjo M; Kawai-Noma S; Taguchi H
    FEBS J; 2015 Feb; 282(3):477-90. PubMed ID: 25406629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.